Answers are grounded in this paper and cite their sources.
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
No takes yet. Share an insight, caveat, or question.
Kulke et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: